Publications by authors named "Zubaryev M"
Article Synopsis
- Clinical research plays a vital role in shaping national strategies for cancer control.
- Before the Russian invasion on February 24, 2022, Russia and Ukraine were important players in global clinical trials and cancer research efforts.
- This analysis examines the effects of the ongoing conflict on cancer research in these countries and its implications for the global cancer research community.
Background: The invasion of Ukraine by Russia in February 2022 has resulted in destruction of healthcare infrastructure and triggered the largest wave of internally displaced populations and refugees since World War Two. Conflicts in transitioned countries such as Ukraine create new non-communicable disease (NCD) challenges, especially for cancer care for refugees and humanitarian assistance in host countries. In the early days, rapid attempts were made to model possible impacts.
View Article and Find Full Text PDFImportance: Many randomized clinical trials (RCTs) led by high-income countries (HICs) now enroll patients from lower middle-income countries (LMICs) and upper middle-income countries (UMICs). Although enrolling diverse populations promotes research collaborations, there are issues regarding which countries participate in RCTs and how this participation may contribute to global research.
Objective: To describe which UMICs and LMICs participate in RCTs led by HICs.